title: Lymphoproliferative disorders in chronic hepatitis C.
abstract: Chronic hepatitis C virus (HCV) infection is associated with the development of lymphoproliferative disorders (LPDs). The aim of this investigation was to determine the prevalence and characterization of monoclonal gammopathy and benign and malignant LPDs in individuals with chronic hepatitis C. A total of 233 subjects diagnosed with chronic hepatitis C (male/female ratio: 131/102, median age; 49 years) were studied. Serum and urine were examined for the presence of a monoclonal gammopathy. A bone marrow aspirate and biopsy was obtained in individuals with a monoclonal gammopathy. Thirty-two patients (13.7%, 32 of 233) had a monoclonal gammopathy; 75% of them were benign and were not associated with malignant disorders (24 of 32) while 25% were associated with malignant LPDs or a plasma cell disorder (eight of 32). Two additional subjects without monoclonal gammopathy were diagnosed as having a malignant LPDs. The prevalence of malignant LPDs/plasma cell disorder in individuals with HCV-induced chronic liver disease was 4.3%. No difference was found in terms of disease duration, HCV genotype, viral load, alanine aminotransferase level or histopathologic score between the subjects with or without a monoclonal gammopathy. The presence of mixed cryoglobulinaemia was strongly associated with the presence of an underlying malignant disorder. Hence a monoclonal gammopathy is found in 14% of patients with chronic hepatitis C and is associated with malignant B-cell LPD in more than a quarter of such patients. The prevalence of LPDs in individuals with HCV-induced chronic liver disease is greater than that of the normal healthy population.
authors.affiliation: Department of Medicine, Division of Gastroenterology and Liver Transplantation, Loyola University Medical Center, Maywood, IL, USA. idilman@dialup.ankara.edu.tr
authors.forename: R
authors.initials: R
authors.lastname: Idilman
authors.forename: A
authors.initials: A
authors.lastname: Colantoni
authors.forename: N
authors.initials: N
authors.lastname: De Maria
authors.forename: S
authors.initials: S
authors.lastname: Alkan
authors.forename: S
authors.initials: S
authors.lastname: Nand
authors.forename: D H
authors.initials: DH
authors.lastname: Van Thiel
mesh_terms: D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001853:Bone Marrow / Q000473:pathology; D003449:Cryoglobulinemia / Q000150:complications; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000821:virology; D006801:Humans; D008099:Liver / Q000473:pathology; D008232:Lymphoproliferative Disorders / Q000150:complications* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000150:complications; D010265:Paraproteinemias / Q000150:complications; D010950:Plasma Cells / Q000473:pathology; D015995:Prevalence; D012307:Risk Factors; D019562:Viral Load
chemical_list: D000410:Alanine Transaminase